Davita Inc Revenue Growth Rates (DVA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Davita Inc   (NYSE: DVA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

DVA's Revenue Growth by Quarter and Year

Davita Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DVA/growth
https://api.csimarket.com/api/v1/companies/DVA/fundamentals
https://api.csimarket.com/api/v1/companies/DVA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
DVA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3,578.13
2nd Quarter June 3,554.08
1st Quarter March 3,415.55
FY 10,547.76

DVAs Annual Revenue
Davita Inc 's Revenue in the fiscal year 2025 $ 13,643.07 millions
Davita Inc 's Revenue in the fiscal year 2024 $ 12,815.55 millions
Davita Inc 's Revenue in the fiscal year 2023 $ 12,140.15 millions
Davita Inc 's Revenue in the fiscal year 2022 $ 11,609.89 millions
Davita Inc 's Revenue in the fiscal year 2021 $ 11,618.80 millions




DVA Revenue third quarter 2026 Y/Y Growth Comment
Davita Inc reported Revenue growth of 4.62% year on year in the third quarter 2026, to $ 3,578.13 millions, this is lower than Davita Inc 's recent average Revenue increase of 11.26%.

Looking into third quarter 2026 results within Healthcare Facilities industry 19 other companies have achieved higher Revenue growth. While Davita Inc ' s Revenue increase of 4.62% ranks overall at the positon no. 2348 in the third quarter 2026.


DVA Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4.62 %
2nd Quarter June 5.16 %
1st Quarter March 5.96 %
FY   -

Financial Statements
Davita Inc 's third quarter 2026 Revenue $ 3,578.13 millions DVA's Income Statement
Davita Inc 's third quarter 2025 Revenue $ 3,420.23 millions Quarterly DVA's Income Statement


DVA Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.68 %
2nd Quarter June 4.06 %
1st Quarter March -5.64 %
FY (Year on Year)   -


Back to DVA Growth rate Comparisons >> Back to DVA Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #338
Overall #2348

Revenue Y/Y Growth Statistics
High Average Low
335.19 % 11.26 % -69.14 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #338
Overall #2348
Revenue Y/Y Growth Statistics
High Average Low
335.19 % 11.26 % -69.14 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Davita Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
259.49 % 4.8 % -71.78 %
(Dec 31 2013)  


DVA's III. Quarter Q/Q Revenue Comment
Davita Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.68% quarter on quarter, to $ 3,578.13 millions.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 1703.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #225
Overall #1703
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #225
Overall #1703
Revenue Q/Q Growth Statistics
High Average Low
259.49 % 4.8 % -71.78 %
(Dec 31 2013)  


DVA's III. Quarter Q/Q Revenue Comment
Davita Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.68% quarter on quarter, to $ 3,578.13 millions.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 1703.


Davita Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 14,167.55
Y / Y Revenue Growth (TTM) 6.38 %
Year on Year Revenue Growth Overall Ranking # 1915
Seqeuential Revenue Change (TTM) 1.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 1915


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Davita Inc 's cumulative twelve months Revenue were $ 14,168 millions, company would post below average annual Revenue growth of 1.13% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Davita Inc 's Revenue growth from the 13161.328000000001% growth in Jun 30 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1915, from total ranking in previous quarter at 2172.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 312
Overall # 2068

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
 14.81 %
-46.8 %
(March 31, 2007)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 364
S&P 500 # 2536
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Davita Inc 's cumulative twelve months Revenue were $ 14,168 millions, company would post below average annual Revenue growth of -46.8% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Davita Inc 's Revenue growth from the 13161.328000000001% growth in Jun 30 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1915, from total ranking in previous quarter at 2172.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 312
Overall # 2068

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
14.81 %
-46.8 %
(March 31, 2007)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 364
S&P 500 # 2536




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DVA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Baxter International Inc 8.08%$ 8.078 millions
Tactile Systems Technology Inc 8.07%$ 8.067 millions
Iqvia Holdings Inc 8.00%$ 8.000 millions
Exagen Inc 7.86%$ 7.859 millions
Gyre Therapeutics Inc 7.75%$ 7.754 millions
Stryker Corp7.64%$ 7.644 millions
Bausch and Lomb Corp7.34%$ 7.338 millions
Addus Homecare Corp7.19%$ 7.193 millions
Pacific Biosciences Of California Inc 7.03%$ 7.026 millions
Bristol myers Squibb Company6.93%$ 6.930 millions
Labcorp Holdings Inc 6.92%$ 6.917 millions
Gilead Sciences Inc 6.83%$ 6.835 millions
Arcturus Therapeutics Holdings Inc 6.68%$ 6.682 millions
National Healthcare Corp6.61%$ 6.614 millions
Tenet Healthcare Corp6.47%$ 6.466 millions
Phibro Animal Health Corporation6.32%$ 6.320 millions
Mettler toledo International Inc 6.27%$ 6.273 millions
Agilon Health Inc 5.86%$ 5.864 millions
Johnson and Johnson5.86%$ 5.860 millions
Stoke Therapeutics Inc 5.86%$ 5.860 millions
Genedx Holdings Corp 5.64%$ 5.642 millions
Adma Biologics Inc 5.59%$ 5.595 millions
Innoviva Inc 5.55%$ 5.551 millions
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions


About Davita Inc Revenue Growth Rates (DVA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Davita Inc (CIK 927066).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000927066-26-000134
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Davita Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.